NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDBerotralstat Orladeyo®
(150 mg hard capsules)
 
Respiratory system, Angioedema, 03.04.03
REDC1 Esterase Inhibitor Berinert® Respiratory system, Angioedema, 03.04.03
REDFluocinolone 190microgram Iluvien®
(Intravitreal Implant )
 
Eye, Corticosteroids, 11.04.01
REDGaradacimab Andembry®
(200 mg Solution for injection in pre-filled pen)
 
Respiratory system, Angioedema, 03.04.03
REDLanadelumab Takhzyro®
(300mg solution for injection)
 
Respiratory system, Angioedema, 03.04.03
REDLiothyronine
(Injection)
 
Endocrine system, Thyroid hormones, 06.02.01
REDRanibizumab 10mg/ml intravitreal injection
(Intravitreal Injection )
 
Eye, Subfoveal choroidal neovascularisation, 11.08.02
GREENSodium Chloride 5% eye products  Eye, Tear deficiency, ocular lubricants, and astringents, 11.08.01
Non Formulary items found
Status Description Section
 Lymphoedema garments  Miscellaneous, Medical Devices and other products, 16.01
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Aflibercept Aflibercept [Specialist Drug] Eye, Antineoplastic Drugs, Antineoplastics, Other
Macular Oedema, Retinopathy Of Prematurity
Aflibercept Aflibercept [Specialist Drug] Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Macular Oedema, Retinopathy Of Prematurity
Amiloride  Amiloride Hydrochloride Cardiovascular System, Diuretics, Potassium-Sparing Diuretics
Oedema
Amiloride  Amiloride With Bumetanide Cardiovascular System, Diuretics, Loop Diuretics
Oedema
Amiloride  Amiloride With Bumetanide Cardiovascular System, Diuretics, Potassium-Sparing Diuretics
Oedema
Berotralstat Berotralstat Respiratory System, Drugs Used In Hereditary Angioedema, Kallikrein Inhibitors
Allergic Conditions, Angioedema
Brolucizumab Brolucizumab [Specialist Drug] Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Retinal Disorders, Macular Oedema
Bumetanide Bumetanide Cardiovascular System, Diuretics, Loop Diuretics
Oedema
C1-Esterase C1-Esterase Inhibitor Respiratory System, Drugs Used In Hereditary Angioedema, Complement Regulatory Proteins
Allergic Conditions, Angioedema
Chlortalidone  Chlortalidone Cardiovascular System, Diuretics, Thiazides And Related Diuretics
Oedema
Chlortalidone  Chlortalidone Cardiovascular System, Diuretics, Thiazides And Related Diuretics
Oedema, Ascites
Co-amilofruse Co-Amilofruse Cardiovascular System, Diuretics, Loop Diuretics
Oedema
Co-amilofruse Co-Amilofruse Cardiovascular System, Diuretics, Potassium-Sparing Diuretics
Oedema
Co-amilozide Co-Amilozide Cardiovascular System, Diuretics, Potassium-Sparing Diuretics
Oedema, Ascites
Co-amilozide Co-Amilozide Cardiovascular System, Diuretics, Thiazides And Related Diuretics
Oedema, Ascites
Conestat Conestat Alfa Respiratory System, Drugs Used In Hereditary Angioedema, Complement Regulatory Proteins
Allergic Conditions, Angioedema
Dexamethasone Dexamethasone Eye, Corticosteroids
Retinal Disorders, Macular Oedema
Diamorphine  Diamorphine Hydrochloride Cardiovascular System, Analgesics, Opioids
Oedema
Faricimab  Faricimab [Specialist Drug] Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Retinal Disorders, Macular Oedema
Fluocinolone  Fluocinolone Acetonide Eye, Corticosteroids
Retinal Disorders, Macular Oedema
Furosemide Furosemide Cardiovascular System, Diuretics, Loop Diuretics
Oedema
Furosemide Furosemide With Triamterene Cardiovascular System, Diuretics, Loop Diuretics
Oedema
Furosemide Furosemide With Triamterene Cardiovascular System, Diuretics, Potassium-Sparing Diuretics
Oedema
Garadacimab Garadacimab Respiratory System, Factor Xiia Inhibitors
Allergic Conditions, Angioedema
IcatibantIcatibant Respiratory System, Drugs Used In Hereditary Angioedema, Selective Bradykinin B2 Antagonists
Allergic Conditions, Angioedema
Lanadelumab  Lanadelumab Respiratory System, Drugs Used In Hereditary Angioedema, Kallikrein Inhibitors
Allergic Conditions, Angioedema
Mannitol Mannitol Cardiovascular System, Diuretics, Osmotic Diuretics
Oedema
Mannitol Mannitol Cardiovascular System, Mucolytics
Oedema
Metolazone Metolazone Cardiovascular System, Diuretics, Thiazides And Related Diuretics
Oedema
Ranibizumab  Ranibizumab [Specialist Drug] Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Retinal Disorders, Macular Oedema, Diabetic Retinopathy, Retinopathy Of Prematurity
Spironolactone  Spironolactone Cardiovascular System, Diuretics, Potassium-Sparing Diuretics
Oedema, Ascites
Spironolactone  Spironolactone With Furosemide Cardiovascular System, Diuretics, Loop Diuretics
Oedema
Spironolactone  Spironolactone With Furosemide Cardiovascular System, Diuretics, Potassium-Sparing Diuretics
Oedema
Torasemide  Torasemide Cardiovascular System, Diuretics, Loop Diuretics
Oedema
TriamtereneTriamterene Cardiovascular System, Diuretics, Potassium-Sparing Diuretics
Oedema
Triamterene Triamterene With Chlortalidone Cardiovascular System, Diuretics, Potassium-Sparing Diuretics
Oedema
Triamterene Triamterene With Chlortalidone Cardiovascular System, Diuretics, Thiazides And Related Diuretics
Oedema
XipamideXipamide Cardiovascular System, Diuretics, Thiazides And Related Diuretics
Oedema
Links found
NICE TA 606 Lanadelumab for preventing recurrent attacks of hereditary angioedema
NICE TA 738 Berotralstat for preventing recurrent attacks of hereditary angioedema
NICE TA1004: Faricimab for treating visual impairment caused by macular oedema after retinal vein occlusion
NICE TA1101: Garadacimab for preventing recurrent attacks of hereditary angioedema in people 12 years and over
NICE TA229: Dexamethasone intravitreal implant for the treatment of macular oedema
NICE TA274: Macular oedema (diabetic) - ranibizumab
NICE TA283: Macular oedema (retinal vein occlusion) - ranibizumab: guidance
NICE TA301: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy (replaced by NICE TA953)
NICE TA305: Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion
NICE TA346: Aflibercept for treating diabetic macular oedema
NICE TA349: Dexamethasone intravitreal implant for treating diabetic macular oedema
NICE TA613: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema in phakic eyes after an inadequate response to previous therapy (replaced by NICE TA953)
NICE TA799 Faricimab for treating diabetic macular oedema
NICE TA820: Brolucizumab for treating diabetic macular oedema
NICE TA824: Dexamethasone intravitreal implant for treating diabetic macular oedema
NICE TA953: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema